Biotech News 22 Jan 2024 Oxford starts human testing of Nipah virus vaccine Field lab assistants catch a bat in their net as they collect specimens for their Nipah virus research in the… Pantitra
Biotech News 29 Dec 2023 Researchers develop a novel dry-powder inhaled vaccine platform Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences have proposed a new "nano-micro composite"… Pantitra
Biotech News 13 Dec 2023 Whooping cough vaccines urged, especially in South Public health agencies are encouraging people, especially those in the deep South, to get vaccinated against pertussis, also known as… Pantitra
BioNet News, Pertussis, Publication 06 Dec 2021 A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age Background: A phase 2 randomized-controlled safety and immunogenicity trial evaluating different doses of recombinant acellular pertussis vaccine containing genetically-inactivated pertussis… Supachai
BioNet News, Pertussis, Publication 01 Nov 2018 The Lancet : Infectious Diseases Vaccines containing formalin-inactivated whole-cell Bordetella pertussis strains were first developed in the USA in the 1930s, and manufacturing processes were… Supachai
BioNet News, Dengue, Press Releases 19 Jun 2018 In-Cell-Art, Institut Pasteur & BioNet-Asia fight against the Dengue virus Nantes / Paris / France, 19th of June, 2018 - In-Cell-Art (ICA), a biotechnology company specialized in nanocarrier technologies, BioNet-Asia (BNA), an… Supachai